Calcutta HC: Employee Looking for Another Job with Rival Company Isn’t Contrary  ||  Allahabad HC: Can’t Call Hindu Marriage Invalid Only because it Isn’t Registered  ||  Allahabad HC: Can’t Call Hindu Marriage Invalid Only because it Isn’t Registered  ||  Allahabad HC: No Power on Police to Open History-Sheet on Likes or Dislikes  ||  Rajasthan HC Puts Stay on Installation of Dairy Booth Outside Private Residence  ||  Calcutta HC: Cannot Summon Accused to Produce Incriminating Evidence against Himself  ||  Kerala HC Upholds STA’s decision mandating installation of cameras with Fatigue Detection Censors  ||  SC: Executive Instructions Cannot Override Statutory Recruitment Processes  ||  Delhi Lieutenant Governor’s Notification regarding Evidence of Police officers Put on Hold  ||  SC Issues Notice in Plea to Bring Bar Councils under POSH Act    

Search Results for Tag : Natco Pharma

News

U.S. PTO Rules in Favour of Mylan(29.08.2016)

U.S.Patent and Trademark Office (PTO) has ruled in the favour of Natco Pharma’s marketing partner Mylan, with regard to patent claims pertaining to mu.....

Tags : U.S.Patent and Trademark Office, Natco Pharma, patent claims



Natco Settles Patent Dispute with Gilead in a US Court(15.12.2015)

Natco Pharma along with its partner Alvogen has settled the patent infringement suit with Gilead Sciences Inc. and others over “Tamiflu” in a US court.....

Tags : Natco Pharma , Alvogen, Tamiflu, Patent Dispute



Delhi High Court Awards Natco Pharma Interim Relief in BMS Patents Case(23.07.2019)

Delhi High Court has awarded interim relief to the Hyderabad-based Natco Pharma Ltd in a fresh patents battle, with the court setting aside an injunc.....

Tags : Delhi High Court, Natco Pharma



Celgene Settles Revlimid Patent Dispute with Natco Pharma(24.12.2015)

Natco Pharma Ltd and partner Allergan Plc has settled dispute with US-based drug maker Celgene Corp. in the patent infringement case of the latter’s c.....

Tags : Natco Pharma, Celgene Corp, Revlimid Patent



Disclaimer | Copyright 2025 - All Rights Reserved